Concomitant Pulmonary Tuberculosis and Invasive Aspergillosis Infection in an Immunocompetent Host

Pulmonary tuberculosis (TB) is a common infection in developing countries and is associated with low socioeconomic status. It is considered a serious infection due it its long-term sequelae. Post-TB lung disease decreases life expectancy and increases the risk of recurrent TB infection. It also significantly increases the risk of other bacterial and fungal infections. Aspergillosis develops in the cavitary lesions of TB, worsening them and resulting in a deteriorating clinical situation. Concomitant pulmonary TB (PTB) and invasive aspergillosis is uncommon, particularly in the absence of factors that suppress the immune system. In this report, we describe the case of a healthy young adult without previous structural lung damage who presented with primary PTB and acute invasive aspergillosis infection, discuss the treatment dilemma and provide a literature review. LEARNING POINTS Aspergillosis can mimic tuberculosis (TB) infection. Concomitant pulmonary TB and invasive aspergillosis is uncommon. The co-administration of antifungal and anti-TB medications presents significant therapeutic challenges.

[1]  A. Fernando,et al.  Triple infection with disseminated tuberculosis, invasive aspergillosis and COVID-19 in an organ transplant recipient with iatrogenic immunosuppression , 2021, BMJ Case Reports.

[2]  M. Brelen,et al.  The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area , 2021, International Ophthalmology.

[3]  A. Khaledi,et al.  Aspergillus coinfection among patients with pulmonary tuberculosis in Asia and Africa countries; A systematic review and meta-analysis of cross-sectional studies. , 2020, Microbial pathogenesis.

[4]  F. Botterel,et al.  Concomitant Presence of Aspergillus Species and Mycobacterium Species in the Respiratory Tract of Patients: Underestimated Co-occurrence? , 2020, Frontiers in Microbiology.

[5]  M. Vargas,et al.  Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease , 2019, IDCases.

[6]  T. West,et al.  Tuberculosis and other bacterial co-infection in Cambodia: a single center retrospective cross-sectional study , 2019, BMC Pulmonary Medicine.

[7]  A. Khaledi,et al.  Tuberculosis Status and Coinfection of Pulmonary Fungal Infections in Patients Referred to Reference Laboratory of Health Centers Ghaemshahr City during 2007–2017 , 2018, Ethiopian journal of health sciences.

[8]  M. Chang,et al.  Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients , 2017, Journal of clinical pharmacy and therapeutics.

[9]  D. Denning,et al.  Chronic pulmonary aspergillosis as a cause of smear-negative TB and/or TB treatment failure in Nigerians. , 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  M. Pai,et al.  Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Catherine Beigelman-Aubry,et al.  Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management , 2015, European Respiratory Journal.

[13]  Alimuddin Zumla,et al.  Clinical Aspects of Adult Tuberculosis. , 2015, Cold Spring Harbor perspectives in medicine.

[14]  A. Sastry,et al.  Prevalence of Invasive Aspergillosis Among (PTB) Patients in Kanchipuram, India. , 2014, Journal of clinical and diagnostic research : JCDR.

[15]  M. Pai Diagnosis of pulmonary tuberculosis: recent advances. , 2013, Journal of the Indian Medical Association.

[16]  N. Osman,et al.  Microarray detection of fungal infection in pulmonary tuberculosis , 2013 .

[17]  T. Peláez,et al.  Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  M. Rai,et al.  Emerging of Mycotic Infection in Patients Infected with Mycobacterium tuberculosis , 2008 .

[19]  G. Mikus,et al.  Induction of Voriconazole Metabolism by Rifampin in a Patient with Acute Myeloid Leukemia: Importance of Interdisciplinary Communication To Prevent Treatment Errors with Complex Medications , 2007, Antimicrobial Agents and Chemotherapy.

[20]  D. Denning,et al.  Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  I. Smith,et al.  Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence , 2003, Clinical Microbiology Reviews.

[22]  A. Kindo,et al.  Rare co-existence of Salmonella typhi and mycobacteria tuberculosis in a psoas abscess--a case report. , 2001, Indian journal of pathology & microbiology.

[23]  M. Brook,et al.  Clinical features and management of two cases of Streptococcus milleri chest infection. , 1988, Scandinavian journal of infectious diseases.